7NEE
Inhibitor Complex with Thrombin Activatable Fibrinolysis inhibitor (TAFIa)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 23-ID-B |
Synchrotron site | APS |
Beamline | 23-ID-B |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-12-07 |
Detector | ADSC QUANTUM 4 |
Wavelength(s) | 1.03324 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 64.170, 95.500, 157.220 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.384 - 2.550 |
Rwork | 0.254 |
R-free | 0.31560 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | in house model |
RMSD bond length | 0.010 |
RMSD bond angle | 1.860 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 37.384 | 2.660 |
High resolution limit [Å] | 2.550 | 2.550 |
Number of reflections | 15499 | 1862 |
<I/σ(I)> | 9.5 | |
Completeness [%] | 96.2 | |
Redundancy | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 293 | 23% PEG 8000, 200mM Ammonium Citrate, 100 mM MES |